Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor cells within the cryoablation zone represent a localized population of malignant tissue targeted for destruction via extreme cold, typically using liquid nitrogen or argon gas. This process, known as cryoablation, induces cell death through two primary mechanisms: direct cellular injury from ice crystal formation and indirect vascular injury leading to ischemia and necrosis (NIH, 2023). As the temperature drops, the formation of intracellular ice ruptures cell membranes and organelles, while extracellular ice creates osmotic shifts that dehydrate the cells. Following the procedure, the remaining cellular debris in the ablation zone serves as a source of tumor-associated antigens, which can be recognized by the immune system to potentially induce a systemic anti-tumor response, often referred to as the abscopal effect (PubMed, 2021). While not a single molecular receptor, this zone is increasingly viewed as a therapeutic focal point for combination treatments involving immunotherapy, such as checkpoint inhibitors, to leverage the immunogenic cell death caused by the freezing process. Clinical success depends on ensuring the ice ball extends beyond the tumor margins to prevent local recurrence while sparing adjacent healthy structures (StatPearls, 2023).
Cryoablation induces cell death through direct cryoinjury (ice crystal formation), vascular stasis (ischemia), and the induction of apoptosis and necrosis. This process releases tumor-associated antigens into the systemic circulation, potentially stimulating an anti-tumor immune response (PubMed, 2021).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cells within the cryoablation zone.